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Abstract.  A potential  regulatory linkage between the 
biosynthesis of colligin,  a collagen-binding protein of 
the ER, and procollagen I was examined under a vari- 
ety of experimental conditions.  Cell lines which did 
not produce a  significant amount of procoUagen I 
mRNA also lacked the capacity to produce colligin 
mRNA.  Anchorage-dependent cell lines like L6 myo- 
blasts and normal rat kidney fibroblasts produced both 
colligin and procollagen I mRNA, but the level of 
both was concurrently reduced considerably in their 
ras-transformed counterparts.  Similarly,  during  the 
differentiation of L6 myoblasts, levels of both colligin 
and procollagen declined together.  Treatment of myo- 
blasts by dexamethasone or EGF led to a decrease in 
the steady-state levels of procollagen I mRNA, and 
this was, again,  accompanied by a decrease in colligin 
mRNA synthesis.  On the other hand,  when the rate of 
procollagen I synthesis was stimulated by treatment of 
myoblasts with TGF/3,  it led to the concurrent aug- 
mentation of both the mRNA and protein levels of 
colligin.  A  linkage between the regulation of synthesis 
of procollagen I and colligin thus seems to exist.  The 
only exception to this generalization  is provided by the 
heat induction behavior of the two proteins.  Treatment 
of myoblasts for a very short period leads to an in- 
crease in the synthesis of both the mRNA and protein 
levels of colligin.  This,  however, is not accompanied 
by a change in the mRNA levels of procollagen I. 
These studies establish that colligin and procollagen 
are generally tightly co-regulated except after heat 
shock,  suggesting an important  functional linkage. 
W 
'E have earlier characterized  a 46-kD glycoprotein 
(termed gp46) from L6 rat skeletal myoblasts (Cates 
et al., 1984; Nandan et al., 1990a) and have shown 
that it binds collagen I, collagen IV, and gelatin (Cates et al., 
1987b). We have cloned the mRNA for gp46 from rat myo- 
blasts (Clarke et al.,  1991) and human fibroblasts  (Clarke 
and Sanwal,  1992) and have shown that it is closely related 
to hsp47 described from chick embryo fibroblasts (Hirayoshi 
et al., 1991) and J6 described from mouse embryonal carci- 
noma cells (Wang and Gudas, 1990). Since the protein was 
first reported by Kurkinen et al. (1984) from murine parietal 
endoderm cells under the name "colligin," it is appropriate 
to designate gp46 from rat (Cates et al., 1984), hsp47 from 
chick (Hirayoshi et al., 1991) and J6 from mouse (Wang and 
Gudas, 1990) as tissue and organism-specific  forms of colli- 
gin.  Colligin  is not only a collagen-binding  protein, but is 
also a serpin,  i.e., a member of the serine protease inhibitor 
family  (Carrell  and  Boswell,  1986;  Clarke  et  al.,  1991; 
Clarke and Sanwal,  1992; Hirayoshi et al.,  1991; Wang and 
Gudas, 1990). As is well known, most of the serpins except 
leukocyte  elastase  inhibitor  (Potempa  et  al.,  1988)  are 
secreted proteins and most act as serine protease inhibitors, 
although  some, like the cortisol- and thyroxine-binding  pro- 
teins  are  noninhibitory  (Carrell  and  Boswell,  1986). 
Whether colligin belongs to the inhibitory or noninhibitory 
class of serpins is yet to be determined, the one fact that sets 
it  apart  from  other  serpins  is  its  localization  to  the  ER 
(Nagata and Yamada, 1986; Nandan et al., 1988). This loca- 
tion coupled to its collagen binding property raises some im- 
portant questions regarding its function.  The collagen bind- 
ing ability of colligin  has led to the suggestion that  it may 
function  as a molecular chaperone (Ellis and Van der Veis, 
1991; Nakai et al.,  1992) for the synthesis of collagen I and 
IV in various tissues (Cates et al.,  1984,  1987b; Kurkinen 
et al.,  1984; Saga et al.,  1987),  although  it might  equally 
well serve some other unknown function in the biosynthesis 
of collagen.  In some preliminary  experiments we had shown 
(Clarke et al., 1991; Nandan et al., 1990b) that the levels of 
colligin and collagen I and IV are regulated  both positively 
and  negatively  in  parallel  under  some conditions.  Thus, 
ethyl-3,4-dihydroxybenzoate  (an  analogue  of ascorbate re- 
quired  for  posttranslational  modification  of collagen),  a 
specific inhibitor  of collagen  I synthesis,  also inhibited  the 
synthesis  of colligin  in skeletal  myoblasts  (Nandan  et al., 
1990b). Similarly, when F9 embryonal carcinoma cells were 
induced to differentiate by retinoic acid and cAMP, they be- 
gan to produce collagen IV. Under these conditions  colligin 
was also induced in parallel  with  collagen  (Clarke et al., 
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of both collagen and colligin synthesis indirecdy suggested 
a functional relationship between the two. For instance, if  the 
synthesis  or  assembly  of  procollagen  I  chains  required 
stoichiometric amounts of colligin, one could conceivably 
expect its level to rise under conditions where procollagen 
I levels are increased. Conversely, when procollagen synthe- 
sis is suppressed, a corresponding or parallel decrease in the 
synthesis of colligin may occur to maintain the stoichiome- 
try of association between the two macromolecules. 
The synthesis of collagen I  is modulated under diverse 
conditions in cells in culture, and we decided to investigate 
whether, and to what extent, colligin levels are also co-regu- 
lated with collagen under these conditions. We were partic- 
ularly interested in the regulation of colligin by growth fac- 
tors such as TGFB, EGF, and by glucocorticoids. All of these 
compounds modulate the synthesis of  collagen I (Hiirniiliiinen 
et al.,  1985;  Ignotz et al.,  1987; Kurata and Hata,  199I). 
Materials and Methods 
Cell Lines and Cell Culture 
The rat skeletal myoblast line, Lt, fibreblast line, 3T3, and neuroblastoma 
cell line, C1300,  were plated at an initial density of 5  x  10  ~ cells per 100- 
mm plate in a-essential medium (a-MEM) supplemented with 50 #g/ml 
gentamycin,  16 mM glucose, and  10%  horse serum as described earlier 
(Cates et al.,  1987a).  K562,  a  human erythroleukemic line, and Friend 
ceils, a  line of mouse erythroleukemic cells were suspended at an initial 
density of 5  x  10  ~ ceUs/ml in a volume of 50 ml of medium RPMI 1640 
(GIBCO BRL, Gaithersborg, MD),  10%  FCS and 50 ~tg/ml gentamycin. 
F9 embryonic carcinoma cells were grown on gelatin-coated plates in 10% 
FCS. 
L6ras2A cell line was made by transfecting L6 by plasmid pF_.JNEO (Bell 
et al.,  1986)  donated to us by Dr. John Bell, University of Ottawa. This 
plasmid was constructed by ligation of the 6.6 kb BamHI fragment of pEJ 
(Tabin ct al., 1980),  which contains the human ms gene with an oncogenic 
gly-val point mutation at codon 21,  into the BamHI site of pSV2NEO. 
Isolation of  ProcoUagen 
L6 ceils were grown to near confluency, and then placed into serum-free 
medium with or without added growth factors. After a  16-h incubation at 
37°C, the cells were exposed for 15 rain to a solution containing 0.1 mM 
each of B-aminopropionitrile and ascorbate. 25 #Ci/mi of L-(5-3H)  proline 
(specific activity 26 Ci/mmol) was then added to the medium and incubation 
was continued for 3 h. At the end of the incubation period, protease inhibi- 
tor's (PMSF, 0.5 mM, EGTA, 4 mM and leupeptin, 2 #g/ml) were added, 
and labeled procollagen was isolated as described previously (Bateman and 
Peterkofsky, 1981) by ammonium sulfate precipitation. To extract cellular 
procollagen, labeled cells were washed extensively with cold PBS and ex- 
tracted with 0.5 M acetic acid containing the mixture ofprotease inhibitors. 
Cells were passed three times through a 27-gauge  needle and the contents 
were left on ice for 30 min. The insoluble material was removed by centrifu- 
gation. The supernatant was neutralized and lyophilized. This material was 
heated in Laemmli sample buffer (Laemmli, 1970),  and the proteins were 
separated by 6 % SDS-PAGE. The gels were stained, destalned, treated with 
EN3HANCE  (NEN Research Products;  New England Nuclear,  Boston, 
MA) for45 rain, dried, and exposed to Kodak X-OMAT film (Eastman Ko- 
dak Co., Rochester, NY). Identification of procollagen chains was achieved 
by using molecular weight standards (Miller and Rhodes, 1982;  Sage and 
Bornstein, 1982). 
D NA Probes 
The EcoRI fragment of piP1, a subelone of pEll (Clarke et al., 1991) was 
used as a rat colligin probe. The insert contains 75 % of the coding region 
towards the COOH terminus (amino acid residues 104-400) and contains 
140  bp  of  3'-untranslated  region.  Rat  collagen  proeq(1)  (pcqR1)  and 
pro~x2(I) (pot2R2) eDNA clones were obtained from Dr. D. Rowe (Univer- 
sity of Connecticut Medical Center, Farmington, Connecticut). The p,~Rl 
plasmid harbored a  1.3-kb insert coding for amino acids 400 through 943 
in  the  triple  helical  domain  of  the  proext(I)  chain,  ligated  into  the 
PstI/BamH1 sites of pUCl 8 (Smith and Niles, 1980).  Plasmid pcx2R2 com- 
prised of a 0.9-kb insert coding for the carboxy-terminal extension peptide 
of proot2(I) ligated into the PstI site of pUC18.  A chicken B-actin eDNA 
probe (Cleveland et al.,  1980),  containing the complete coding and 3'- 
untranslated regions, was obtained from Dr. D. W. Cleveland (Johns Hop- 
kins University, Baltimore, MD). All probes were isolated away from their 
respective plasmids before being labeled with (~x32p)-dCTP using a mix- 
ture of random hexanucleotides to prime in vitro DNA synthesis (Feinburg 
and Vogelstein, 1983). 
Northern Blotting and RNA Slot Blots 
For  Northerns,  poly(A)-tailed RNA  or  total  RNA  was denatured with 
glyoxal and separated on  1%  agarose gels containing sodium phosphate 
(Smith and Niles, 1980).  Electrephoresed RNA was then transferred to Bio- 
trans nylon membranes (ICN Biochemicals, NY). For slot blots, various 
amounts of total RNA of each sample were slot blotted using the Schleicher 
and Schuell Minifold II (Schleicher and Schuell, Inc., Keene, NH). The 
filters were prehybridized at 420C for 3 h and then hybridized at 42*(: for 
12-24 h in a solution containing 50% formamide, 5x SSC, 5x Denhardt's 
solution (Denhardt, 1966),  denatured salmon sperm DNA, 0.1% SDS and 
denatured DNA probes. Blots were washed twice in 2x  SSC containing 
0.1% SDS at room temperature for 5 rain each. Blots probed with rat colli- 
gin and B-actin were subsequently washed twice with (}.Ix  SSC and 0.1% 
SDS at 42"C for 20 rain each. Blots probed with the collagen probes were 
washed twice with 0.1x SSC containing 0.1% SDS at 60°C for 10 min each. 
Filters were exposed to Kodak XAR-5 film at  -70"C for various lengths 
of time. 
Western Blotting 
Monolayers were washed once with cold PBS and the cells were scraped 
into 1% SDS heated to 90oc. Samples were stored frozen at -20°C before 
use. Protein was quantitated using a modification (Paterson, 1977) of the 
Lowry procedure (~ry  et al.,  1951). Aliquots of cell extracts were run 
on 9%  SDS-polyacrylamide gels as described by  Laemmli  (Laemmli, 
1970).  Electrophoresed proteins were then electroblotted onto nitrocellu- 
lose membranes for 75 vain at II0 V using a Bio-Rad Trans-blot apparatus 
(Bio-Rad/Analytical  Instr.  Group,  Cambridge,  MA)  and  stained  with 
Amido black.  After washing with TBS,  the blots were blocked for  1 h 
at 37°C with 4% BSA, and then incubated overnight at room temperature 
in buffer containing affinity purified anti-colligin antibody (Cates et al., 
1987b) or anti-protein disulfide isomerase antibody (Dimension Laborato- 
ries, Ontario, Canada). Blots were then washed 4 times with 0.01% "lYiton 
X-100 in Tris buffer for 10 min each and incubated for 3 h in 4% BSA in 
TBS  containing 0.1  #Ci/ml  125I-labeled goat anti-mouse IgG  antibody. 
Blots were washed again, dried and autoradiographed at  -70°C. 
Densitometry 
Protein and RNA signals in autoradiograms were scanned using an LKB 
Ultroscan XL laser densitometer. A value of 1 was assigned to the intensity 
of  bands in control lanes and all values were expressed relative to this value. 
Film responses were in the linear range when quantitation from autoradio- 
grams was performed. 
Results 
Colligin and ProcoUagen I Transcripts in Cell Lines 
Starting  with the assumption that cell lines which are not 
stringent in their requirement for attachment  to a surface for 
growth may lack or have diminished ability to produce colla- 
gen I, we tested several such lines and found that they do not 
have  significant  amounts  of procollagen  at(I)  and  a2(I) 
mRNA compared with cell lines which require  attachment 
to substrate  for growth (Fig.  1 A). The former types of cell 
lines also had insignificant amounts of colligin mRNA, while 
cell lines which produced larger  amounts of procollagen I 
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Figure 2. Levels of colligin and procollagen I mRNA during myo- 
blast differentiation. 10 #g of  total RNA, isolated from L6 cells af- 
ter various days in culture, were slot blotted onto a nylon filter and 
probed with various DNA probes. The blots were successively hy- 
bridized to colligin and procollagen I DNA probes. The autoradio- 
grams from each hybridization were scanned and the relative absor- 
bances were plotted. For each probe, the values were normalized 
with respect to relative absorhancy 48 h after  plating. Days 2-5 rep- 
resent L6 cells grown in culture for 48, 72, 96, and 120 h, respec- 
tively. ([]) Colligin;  (o) procollagen ¢xl(I); and (I) procollagen 
Ot2(I). 
Figure L  Levels of colligin and procollagen I mRNA in various 
cell lines. (.4) 20 #g of total RNA, isolated for each cell line indi- 
cated,  was  denatured  with  glyoxal and  electrophoresed  on  1% 
agarose gels before transferring to nylon filters and probing with 
the indicated DNA probes in a sequential manner. (B) Northern 
blots for L6ras2A were scanned by laser densitometry, and the rel- 
ative absorbances were normalized to value obtained with L6. (u) 
values for colligin; (~) proeollagen at(l); and (m) a2(I). 
mRNA correspondingly had higher levels of  colligin mRNA. 
A striking correlation between the levels of the mRNA of the 
two proteins was seen in normal L6 myoblasts and NRK fibro- 
blasts and their ms-transformed counterparts (NRKras and 
L6ras2A; Fig. 1 B). The normal cells require attachment to 
substratum for growth (and in the case of L6 for differentia- 
tion), while the transformed cells can grow on soft agar and 
are anchorage independent. The mRNA levels ofprocollagen 
and colligin are both reduced considerably in the transformed 
lines. This reduction is not due to general decrease of RNA 
synthesis in the transformed cells. Levels of/~-actin mRNA, 
for instance, are unaltered in L6ras2A compared with L6. 
Procollagen and CoUigin Transcripts during 
Myoblast Differentiation 
It is known that skeletal myoblasts produce collagen I, but 
during their differentiation into myotubes, its level decreases 
(Nusgens et al.,  1986). In view of the correlation observed 
between  colligin  and  procollagen I  levels  in  various  cell 
lines, we wanted to find if these proteins are co-regulated 
during  differentiation.  Under  our  culture  conditions,  L6 
myoblasts align themselves in arrays on approximately the 
third day of culture, and begin to fuse on the fifth day. The 
mRNA levels of procollagen otl(I) and oL2(I)  chains increase 
significantly on the third day and then decrease to almost half 
just before fusion. Interestingly, and in conformity with the 
results described above, the mRNA levels of  colligin also fol- 
low the same trend as the procollagen chains (Fig. 2). We 
had earlier demonstrated (Cates et al., 1987b) that the levels 
of the protein decrease during differentiation. The decrease 
in the levels of colligin does not reflect a general decline in 
the biosynthesis of proteins during myoblast differentiation. 
We  have  shown  earlier  (Lorimer et  al.,  1987)  that  the 
DNA/RNA ratios do not significantly change during myo- 
genesis. 
Effect of  Dexamethasone on Procollagen I and 
CoUigin Levels in Myoblasts 
It has  been shown by several workers in various  systems 
(Raghow et al.,  1986; Weiner et al.,  1987) that glucocorti- 
coids inhibit the expression of type I collagen through both 
transcriptional  and  posttranscriptional  regulatory  mecha- 
nisms. It was of  interest to determine if  the synthesis of  coUa- 
gen I is also suppressed in myoblasts, and more importantly, 
if this suppression is accompanied by the inhibition of syn- 
thesis of colligin mRNA. Fig. 3 shows that colligin mRNA 
levels decrease after dexamethasone  treatment  as  do  the 
procollagen I mRNA levels. When myoblasts are exposed to 
dexamethasone over a period of several days it leads to the 
inhibition of differentiation and the synthesis of mRNA of 
differentiation-related proteins such as troponin C and myo- 
sin light chain in myoblasts (our own unpublished observa- 
tions), but levels of the mRNA of a "housekeeping" protein 
such as/~-actin, both in the short as well as long term, are 
not affected by the glucocorticoid. The effect on collagen I 
and colligin mRNA thus seems to be more specific. 
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pmt~t(I),  and  proa2(I)  collagen.  L6 cells  were  grown  to  near 
confluency (3 d) and then placed in medium containing TGF/3  (0.25 
ng/ml, lane 2 and 0.50 ng/ml, lane 3) or EGF (10 ng/ml, lane 4 
and 50 ng/ml, lane 5). Lane I is control (no growth factors). After 
12 h of treatment, the cells were harvested, total RNA extracted, 
and subjected to Northern blot analysis and autoradiography as de- 
scribed in Fig.  1. 
Figure 3.  Effects of dexamethasone on the levels of colligin and 
procoUagen I mRNA. 20 #g of total RNA from each sample was 
treated as described in Fig. 1. L6 cells were grown in culture for 
24 h, after which 5 #g/ml of dexamethasone was added directly to 
the medium. RNA was isolated from cells with (+) or without (-) 
dexamethasone treatment after 120 h in culture.  Data  from au- 
toradiograms is presented in the inset. The relative absorbancy is 
presented in the histogram. (=) Colligin; ([]) t~l(I); and (m) c~2(I) 
procollagen chains. 
Effect of Growth Factors on the Biosynthesis of 
ProcoUagen I and CoUigin in Myoblasts 
There are two well-known growth factors, TGF/~ and EGE 
which have opposite effects on the biosynthesis of collagen 
I in various cells. TGF/~ not only inhibits myogenesis (Heino 
and  Massagu~,  1990;  Massagu~,  1990;  Massagu6  et al., 
1986)  but also upregulates the synthesis of collagen I  and 
several other extracellular matrix (ECM) t constituents (Mas- 
sagu6,  1990). In addition, it activates production of PAId, 
which, like colligin, is a  serpin (Andreasen et al.,  1990). 
EGE on the other hand, inhibits the transcription of collagen 
I genes in skin fibroblasts CKurata and Hata, 1991). The op- 
posite effects  of  the two growth factors on collagen I synthesis 
allowed us to ask if  the levels of  colligin are co-regulated with 
those of collagen I. In conformity with earlier results (Mas- 
sagu6 et al., 1986) TGF/~ increased the steady-state levels of 
procollagen I mRNA in myoblasts (Fig. 4). EGF on the other 
hand, much like in fibroblasts CKurata and Hata, 1991), de- 
creased these levels in myoblasts (Fig. 4). The interesting ob- 
servation, however, is that the mRNA levels ofcolligin  change 
in the same way as procollagen I, i.e., they increase in the 
presence of TGF/3 and decrease in the presence of EGF (Fig. 
4). For a 12-h exposure period for the growth factors, maxi- 
mUm effect was brought about by 0.5 ng/ml TGF/~ (Fig. 4) 
and 50 ng/rnl EGE The change in the steady-state levels of 
mRNA for both procollagen I and colligin in the presence 
of  growth factors were accompanied by corresponding changes 
in the protein levels. This is shown in Fig. 5 for TGF/3. We 
ascertained that the concentration of another protein imme- 
diately connected with procoUagen synthesis in vivo (Nakai 
et al., 1992), viz., PDI, a subunit of prolyl hydroxylase, and 
/~-macroglobulin, a housekeeping protein, did not change in 
1. Abbreviation  used in this paper: ECM, extracellular  matrix. 
the presence of the growth factors (N. Jain, E. Clarke, and 
B. D.  Sanwal, unpublished observations). 
Absence of Co-regulation of Procollagen I and CoUigin 
during Heat Shock 
It has been demonstrated earlier (Cates et al., 1987b; Nagata 
et al.,  1986; Saga et al.,  1987) that colligin is a heat shock 
protein. Brief exposure of myoblasts (4 h) to 42 and 44°C 
increases its level. Heat treatment also leads to an increase 
in the levels of colligin mRNA (Fig. 6). Other common pro- 
teins in myoblasts, such as/~-actin,  are unaffected by heat 
treatment. ProcoUagen I mRNA levels are also not signifi- 
cantly affected by heat (Fig. 6). 
Discussion 
The aim of this investigation was to find clues to the function 
of the collagen-binding protein coUigin (Clarke et al., 1991; 
Clarke and Sanwal,  1992; Hirayoshi et al.,  1991; Kurkinen 
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Figure 5. Effect of TGF~ on the induction of colligin (n), prootl(I) 
(~) and proc~2(I) ([]) protein levels in L6 myoblasts. Subconfluent 
cells were placed in culture medium with the growth factor (0.25 
ng/ml or 0.5 ng/ml). After 12 h of  treatment, cells were lysed, total 
protein was extracted and subjected to Western blot analysis for de- 
tecting colligin levels. Procollagen was isolated and analyzed as de- 
scribed  in  Materials  and  Methods. The  autoradiographs  were 
scanned,  and  the  values  were  normalized  to  control  (without 
TGFI3). 
The Journal of Cell Biology,  Volume 121, 1993  196 Figure  6.  Levels of colligin 
and procollagen  I mRNAs  dur- 
ing heat shock. L6 ceils were 
cultured for 72 h before expo- 
sure to temperatures of  42 and 
44"C for 4 h. 20 #g of RNA 
from each sample was slot blotted onto a nylon filter and probed 
sequentially with the indicated DNA probes. 
et ai., 1984; Wang and Gudas, 1990).  Two observations that 
suggested that coUigin may have a role to play in the biosyn- 
thesis ofprocollagen I were: first, that it bound tightly to col- 
lagen I and collagen IV (Cates et al., 1984,  1991; Kurkinen 
et al., 1984; Nagata and Yamada,  1986); and second, it was 
localized to the lumen of the ER, as judged by the presence 
of an ER-retention signal, RDEL, at its carboxyl terminus 
(Clarke et al.,  1991), and by immunofluorescence (Nandan 
et al.,  1988) and electron microscopic studies (Nagata and 
Yamada,  1986;  Saga et al.,  1987) of its localization. Since 
procollagen is synthesized in the ER, colligin could be in- 
volved in any one of  the following aspects of  proeollagen bio- 
synthesis. It could be acting as a chaperone (Nakai et al., 
1992) in the intracellular processing of  procollagen. Because 
colligin is a serpin, it could equally well be involved in the 
protection of the nascent procollagen chains from attack by 
yet unknown serine protease(s) in the ER. Indeed, there is 
now firm evidence for the presence of some protein degrada- 
tive enzymes in the ER compartment itself (Klausner and 
Sitia, 1990; Wikstrom and Lodish, 1992). Results presented 
here are compatible with either one of these possibilities. 
Further experimentation will be needed to establish the role 
of colligin in the synthesis of procollagen I. 
We have shown that under a variety of conditions where 
the level of mRNA for collagen ot~(I)  and ~2(I) decreases, 
there is also a concurrent decrease in the level of colligin 
mRNA. Such, for instance, is the case during the differentia- 
tion of L6 myoblasts. It has been shown by several workers 
that during differentiation of myoblasts secretion of collagen 
I decreases and is replaced by collagen III (Nusgens et ai., 
1986).  This observation is in agreement with our data re- 
garding the diminution of the steady-state levels of mRNA 
for procollagen I (and concurrently colligin) during differen- 
tiation. We had earlier shown that DNA/RNA ratios remain 
unchanged during myogenesis (Lorimer et al., 1987); the de- 
crease, thus, is not a consequence of a general decrease in 
RNA synthesis. Similarly, transformed cells are known to 
produce  smaller  amounts  of procollagen  I  mRNA  (Av- 
vedimento et al., 1981; Sandmeyer et al., 1981), and we have 
found the same to be true of ras-transformed myoblasts and 
NRK cells. Here, again, there is a parallel decrease in the 
content of colligin mRNA,  compared with untransformed 
cells. Further, ceils which can grow in suspension and have 
no apparent need for the presence of ECM components in 
the medium, produce little or insignificant amounts of pro- 
collagen I mRNA. Correspondingly, in these cells colligin 
mRNA is barely detectable. It has been reported that dexa- 
methasone decreases the levels ofprocollagen I (H~a~iinen 
et al., 1985; Weiner et al., 1987) by both transcriptional and 
posttranscriptional mechanisms. We have shown that colligin 
steady-state mRNA levels are also decreased significantly 
compared to untreated cells. If  present throughout the course 
of myogenesis in culture, dexamethasone also inhibits differ- 
entiation and decreases the levels of mRNA for several pro- 
teins, such as myosin light chain and troponin, but short-term 
exposure of undifferentiated cells to the hormone does not 
lead to generalized decrease of mRNA synthesis. Growth 
factor EGF, like the steroid hormones, inhibits the synthesis 
of both procollagen I mRNA and protein, and this again is 
accompanied by decrease of  mRNA and protein levels of col- 
ligin. It is clear that negative regulation of procollagen I is 
accompanied by negative regulation of colligin. We had also 
shown earlier (Nandan et al.,  1990b)  a similar co-relation 
in the case of ethyl dihydroxybenzoate, a potent inhibitor of 
procollagen mRNA and protein synthesis. 
The relationship between synthesis of procollagen I and 
coUigin  also holds for positive regulation.  Growth factor 
TGF/~ is known to upregulate the synthesis of procollagen I 
(and several other ECM constituents) in L6 myoblasts (Ig- 
notz et al., 1987). Our results confirm that finding. However, 
more interesting from our point of view is that this upregula- 
tion is accompanied by increase in the mRNA and protein 
levels of coUigin. Unlike the diversity and numbers of nega- 
tive regulators, very few positive regulators of procollagen 
I synthesis are known, and further work will have to be un- 
dertaken with tissues where a remodeling of the ECM takes 
place and procollagen I synthesis becomes dominant (Hay, 
1981) to see if appearance of procollagen I is accompanied 
by colligin synthesis. However, we (Clarke et al., 1991) and 
others (Hirayoshi et ai., 1991) have already shown that dur- 
ing F9 embryonal carcinoma cell differentiation, procolla- 
gen IV synthesis increases in parallel with colligin. Undif- 
ferentiated cells lack both of these proteins and can grow in 
suspension.  Colligin binds to collagen I  and collagen IV 
equally well (Kurkinen et al., 1984),  despite the differences 
in their structure, and it is very likely that colligin has the 
same biosynthetic relationship with collagen IV as it has with 
collagen I. 
It may be pointed out that growth factors, such as TGF~, 
are known to upregulate the synthesis of several  ECM or 
ECM-related constituents, like fibronectin, tenascin, throm- 
bospondin, and certain proteoglycans (Massagut, 1990), but 
none of these substances bind to procoUagen  I, if at all, as 
specifically and as tightly as does colligin. In fact, it has been 
shown that in addition to colligin, only PDI, a few stress pro- 
teins,  and  fibronectin  are  associated  with  procollagen  I 
chains in vivo, in avian fibroblasts (Nakai et al.,  1992) as 
well as in L6 myoblasts (Clarke, E., N. Jain, A. Brickenden, 
E. Ball, and B. D. Sanwal, manuscript in preparation). Obvi- 
ously proteins other than colligin are involved in procollagen 
biosynthesis and/or assembly, but their levels  are not co- 
regulated with those of procollagen I chains. TGF/3, for in- 
stance, which upregulates procollagen I and colligin levels 
in parallel, has no significant effect on PDI levels. This is in 
keeping with results obtained with other cell types (Tsao and 
Grisham, 1991). Similarly, as we have shown earlier, gluco- 
corticoids downregulate procollagen and colligin levels  in 
parallel, but are known, depending upon the cell type, to 
have either no significant effect, or upregulate the synthesis 
of fibronectin (Cutroneo et al.,  1986).  Thus, all molecules 
found associated with procollagen in vivo are not regulated 
in the same way except colligin and procollagen. It is un- 
likely that this coregulation is entirely fortuitous and without 
physiological relevance. 
Clarke et al. Regulation of CoUigin and ProcoUagen 1  197 The only exception we have so far been able to find where 
procollagen I levels are not co-regulated with colligin is the 
heat-induced increase of colligin. Heat induction of colligin 
was first demonstrated (Nagata et al., 1986) in chick embryo 
fibroblasts.  This is also a characteristic of colligin from myo- 
blasts.  Treatment of L6 cells for a few hours at 42 or 44°C 
leads  to  an  increase  in  the  steady-state  levels  of colligin 
mRNA and protein, but levels of procollagen I remain invari- 
ant.  This observation at a first glance seems to suggest that 
co-regulation of colligin and procollagen I under different 
conditions may only be fortuitous. However, if one assumes 
that co-regulation  is due to the  sharing  of some common 
regulatory sequences in the genes governing the synthesis of 
colligin and procoUagen I, and heat induction is due to the 
presence  of heat  shock  elements  only  in  the  genetic  se- 
quences of colligin, a linkage between the synthesis of colli- 
gin and procollagen I would not be evident under some con- 
ditions. The heat induction of colligin suggests that it may 
function in protecting unwound or nascent chains of procol- 
lagen in vivo. 
Apart  from  the  functional  relationship  of  colligin  to 
procollagen, the regulation of colligin as a member of the 
serpin family per se by various growth factors, and under 
different growth conditions, is of great interest because so far 
only one other member of the serpin family, viz., plasmino- 
gen activator  inhibitor (PAI-1), has been found to be suscep- 
tible  to  regulation  by  growth  factors  (Andreasen  et  al., 
1990).  However, while PAI-1 is upregulated  by both TGF~ 
and  EGF,  colligin  levels  are  increased  by  TGF~  and de- 
creased by EGE Just as the members of the serpin family 
differ from each other in regard to their inhibitory character- 
istics and functional properties, it appears that they also arc 
regulated in different ways. 
We would like to thank Pam Icely and Caroline Lohrisch for helping with 
some of the RNA isolation and Northern blotting work. 
This work was supported by the Medical Research Council of Canada. 
N. Jain was supported by a National Scholarship from the Government of 
India. 
Received for publication 23 June 1992 and in revised form  10 December 
1992. 
References 
Andreasan, P. A., B. Georg, L. R. Lurid, A. Riccio, and S. Stacy. 1990. Plas- 
minogun activator inhihitors; hormonally regulated serpins. Mol.  Cell. En- 
docrinol.  68:1-19. 
Avvedimento, E., Y. Yamada, E. Lovelace, G. Vogeli, B. de Crombrugghe, 
and I. Pastan. 1981. Decrease in the levels of nuclear RNA precursors for 
alpha 2 collagen in rons sarcoma virus transformed fibroblasts. Nucleic Acids 
Res.  9:1123-1131. 
Bateman, J. F., and B. Peterkofsky. 1981. Mechanisms  of kirsten murine sar- 
coma virus transformation induced changes in the collagen phenotype and 
synthetic rate of BALB 3T3 cells. Proc.  Natl. Acad. Sci. USA. 78:6028- 
6032. 
Bell, J. C., K. Jardine, and M. W. McBurney. 1986. Lineage-specific transfor- 
mation after differentiation  of multipotential routine stem cells containing a 
human oncogene. Mol. Cell. Biol. 6:617-625. 
Carrell, R. W., and D. R. Boswell. 1986.  Serpins: the superfamily of plasma 
serine proteinase inlubitors. In Proteinase Inhibitors. A. J. Barrett and G. 
Salvesen, editor. Elsevier, Amsterdam. 403-420. 
Cares, G. A., A. M. Brickenden, and B. D. Sanwal. 1984.  Possible involve- 
ment of a cell surface glycoprotein in the differentiation  of skeletal  myo- 
blasts. J.  Biol. Chem. 259:2646-2650. 
Cates, G. A., D. W. Litchfield,  S. Narindrasorasak, D. Nandan, E. H. Ball, 
and B. D. Sanwal. 1987a. Phosphorylation of a gelatin-binding protein from 
L6 myohlasts by protein kinase C. FEBS (Fed. Fur. Biochem.  Soc.) Lett. 
218:195-199. 
Cates,  G.  A., D.  Nandan,  A.  M.  Brickenden, and B.  D.  Sanwal.  1987b. 
Differentiation  defective mutants of skeletal myoblasts altered in a gelatin 
binding glycoprotein. Biochem.  Cell Biol. 65:767-775. 
Clarke, E. P., G. A. Cams, E. H. Ball, and B. D. Sanwal. 1991. A collagen- 
binding protein in the endoplasmic reticulum of myoblasts exhibits relation- 
ship with serine pmtcas¢ inhibitors. J.  Biol. Chem. 266:17230-17235. 
Clarke, E. P., and B. D. Sanwal. 1992. Cloning of a human collagen-binding 
protein, and its homology with rat gp46, chick hsp47 and mouse J6 proteins. 
Biochim.  Biophys. Acta.  1129:246-248. 
Cleveland, D. W., M. A. Lopata, R. J. MacDonald, N. J. Cowan, W. J. Rutter, 
and M.  W.  Kirschner.  1980.  Number and evolutionary conservation of 
a- and ~-tuhnlin and cytoplasmic 8- and v-actin genes using specific cloned 
eDNA probes. Cell. 20:95-105. 
Cutroneo, K. R., K. M. Sterling, Jr., and S. Shull. 1986. Steroid hormone regu- 
lation of extracelhilar matrix proteins. In Regulation of Matrix Accumula- 
tion. R. P. Mecham, editor. Academic Press, New York.  119-176. 
Denhardt, D. T. 1966.  A membrane filter technique for the detection of com- 
plementary DNA. Biochem.  Biophys. Res.  Commun. 23:641-652. 
Ellis, R. J., and S. M. Van der Veis. 1991. Molecular chaperones. Annu. Rev. 
Biochem.  60:321-347. 
Feinhnrg, A. P., and B. Vngelstein. 1983. A technique for radiolabeling DNA 
restriction endonuclease fragments to high specific activity. Anal. Biochem. 
132:6-13. 
H~fiiliinen, L., J. Oikarinen, and K. I. Kivirikko. 1985. Synthesis and degra- 
dation of type I procollagen mRNAs in cultured human skin fibroblasts and 
the effect of cortisol. J.  Biol.  Chem. 260:720-725. 
Hay, E. D. 1981. Cell Biology of Extracellular Matrix. E. D. Hay, editor. Ple- 
num, New York. 379-409. 
Heino, J., and J.  Massagu~. 1990.  Cell adhesion to collagen and decreased 
myogenic gene expression implicated in the control of myngenesis  by trans- 
forming factor beta. J.  Biol. Chem. 265:10181-10184. 
Hirayoshi, K., H. Kudo, H. Takechi, A. Nakai, A. Iwamatsu, K. M. Yamada, 
and K.  Nagata.  1991.  HSP47:  a  tissue-specific transformation-sensitive, 
collagen-binding heat shock protein of chicken embryo fibroblasts.  Mol. 
Cell. Biol. 11:4036-4044. 
Ignotz, R. A., T. Endo, and J. Massagu~. 1987. Regulation of fibronectin and 
type I collagen mRNA levels by transforming growth factor-beta.  J.  Biol. 
Chem. 262:6443-6446. 
Klausner, R. D., and R. Sitia.  1990.  Protein degradation in the endoplasmic 
reticuhiml Cell. 62:611-614. 
Kurata, S., and R. Ham. 1991.  Epidermal growth factor inhibits transcription 
of type I collagen genes and production of type I collagen in cultured human 
skin fibroblasts  in the presence and absence of L-ascorbic acid 2-phnsphate, 
a long acting vitamin C derivative. J.  Biol. Chem. 266:9997-10003. 
Kurkinen, M.,  A. Taylor, J.  I.  Garrels, and B.  L.  M.  Hogan.  1984.  Cell 
surface-associated  proteins which bind native type IV collagen or gelatin. J. 
BioL  Chem. 259:5915-5922. 
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage T4. Nature  (Lond.). 227:680-685. 
Lorimer, I. A. J., M. E. Mason, and B. D. Sanwal.  1987.  Levels of type I 
cAMP-dependent protein kinase regulatory subunit are regulated by changes 
in turnover rate during skeletal  myogenesis. J.  Biol. Chem. 262:17200- 
17205. 
Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein 
measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275. 
Massagu~, J. 1990. The transforming growth factor-~ family. Annu. Rev. Cell 
Biol.  6:597-641. 
Massagu~, J., S. Cheifetz, T. Endo, and B. Nadal-ginard.  1986.  Type beta 
transforming  growth factor is an inhibitor of myogenic differentiation.  Proc. 
Natl. Acad. Sci. USA. 83:8206-8210. 
Miller, E. J., and R. K. Rhodes. 1982. Preparation and characterization of the 
different types of collagen. Methods Enzymol.  82:33-64. 
Nagata, K., and K. M. Yameda. 1986. Phosphorylation and transformation sen- 
sitivity of a major collagen-binding protein of fibroblasts. J. Biol. Chem. 
261:7531-7536. 
Nagata, K., S. Saga, and K. M. Yamada. 1986. A major collagen-binding pro- 
tein of chick embryo fibroblasts is a novel heat shock protein. J.  Cell Biol. 
103:223-229. 
Nakai, A., M. Satoh, K. Hirayoshi, and K. Nagata. 1992. Involvement of the 
stress protein HAP47 in procollagan processing in the endoplasmic reticu- 
lum. J.  Cell Biol.  117:903-914. 
Nandan, D., G. A. Cares, E. H. Ball, and B. D. Sanwal. 1988.  A collagen- 
binding protein involved in the differentiation  of myoblasts recognizes the 
arg-gly-asp sequence. Exp. Cell Res.  179:289-297. 
Nanden, D., G. A. Cates, E. H. Ball, and B. D. Sanwal. 1990a. Partial charac- 
terization of a  collagen-binding, differentiation-related  glycoprotein from 
skeletal  myoblasts. Arch.  Biochem.  Biophys.  278:291-296. 
Nandan, D., E. P. Clarke, E. H. Ball, and B. D. Sanwal.  1990b.  Ethyl-3,4- 
dihydroxybenzoate inhibits myoblast differentiation:  evidence for an essen- 
tial role of collagen. J.  Cell Biol.  110:1673-1679. 
Nusgens, B., D. Delain, H. Senechal, R. Winand, C. M. Lapierre, and J. P. 
Wahrmann.  1986.  Metabolic changes in the extracellular matrix during 
differentiation  of myoblasts of the L6 line and of a myo- non-fusing mutant. 
Exp.  Cell Res.  162:51-62. 
Paterson, G. L. 1977. A simplification  of the protein assay method of Lowry 
et al. which is more generally applicable.  Anal. Biochem.  83:346-356. 
Potempa, J., A. Dobin, W. Watorek, and J. Travis. 1988. An elastase inhibitor 
The Journal of Cell Biology, Volume 121,  1993  198 from equine leukocyte cytosol belongs to the serpin superfamily. J.  Biol. 
Chem.  262:7364-7369. 
Raghow, R., D. Gossage, and A. H. Kang. 1986.  Pretranslational regulation 
of type I collagen, fibronectin, and a 50-kilodalton non-coUagenous  extracel- 
lular protein by dexamethasone in rat fibroblasts. J. Biol.  Chem. 261:4677- 
4684. 
Saga, S., K. Nagata, W.-T. Chen, and K. M. Yamada.  1987.  pH-dependent 
function, purification, and intracellular location of a major collagen-binding 
glycoprotein. J.  Cell Biol.  105:517-527. 
Sage, H~, and P. Borustein. 1982. Preparation and characterization of  the differ- 
ent types of collagen. Methods Enzymol.  82:96-127. 
Sandmeyer, S., B. Gallis, and P. Bornstein. 1981.  Coordinate transcriptional 
regulation of type I procoilagen genes by rous sarcoma virus. J. Biol.  Chem. 
256:5022-5026. 
Smith, B. D., and R. Niles. 1980. Characterization of co|lagen synthesized by 
normal and chemically transformed rat liver epithelial  cell lines. Biochemis- 
try.  19:1820-1825. 
Tabin,  C.  J.,  S.  M.  Bradley,  C.  I.  Bargmann, R.  A.  Weinberg,  A.  G. 
Papageorg, E. M. Scolnick,  R. Dhar, D. R. Lowy, and E. H. Chang. 1980. 
Mechanism of activation of a human oncogene. Nature (Lond.).  300:143- 
149. 
Tsao, M. S., and J. W. Grisham. 1991. Expression of protein disulfide isomar- 
ase in cultured rat liver epithelial  cells is unrelated to the growth inhibitory 
effect of TGF-betal. Biochem.  Biophys.  Res.  Commun.  174:478--482. 
Wang, S. A., and L. J. Gudas. 1990.  A retinoic acid-inducible mRNA from 
F9 teratocarcinoma cells encodes a novel protease inhibitor homologue. J. 
Biol.  Chem.  265:15818-15822. 
Weiner, F. R., M. J. Czaja, D. M. Jefferson, M. Giambronet, R. Tnr-Kaspa, 
L. M. Reid, and M. A. Zern. 1987. The effects of dexamethasone  on in vitro 
collagen gene expression. J.  Biol.  Chem.  262:6955-6958. 
Wikstrom, L., and H. F. Lodish. 1992. Endoplasmic reticulum degradation of 
a subunit  of the asialoglycoprotein receptor in vitro. J. Biol.  Chem. 267:5-8. 
Clarke ¢t el. Regulation of Colligin and Procollagen 1  [99 